Oral human papillomavirus prevalence, persistence, and risk-factors in HIV-positive and at-risk HIV-negative men and women in southwestern Kenya
Acronym:
ORAL HPV
Timeline:
2023 – 2025
Status:
Ongoing
Site Principal Investigators:
Dr. Jesse Gitaka
Dr. Fred Otieno
Funder:
MERCK
Objective:
This study aims to evaluate the prevalence, incidence, persistence, and risk-factors of oral human papillomavirus in HIV-infected and at-risk HIV-uninfected men in southwestern Kenya.